These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8640982)

  • 1. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo.
    Münzel T; Bassenge E
    Circulation; 1996 Jun; 93(11):2052-8. PubMed ID: 8640982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease.
    Münzel T; Heitzer T; Kurz S; Harrison DG; Luhman C; Pape L; Olschewski M; Just H
    J Am Coll Cardiol; 1996 Feb; 27(2):297-303. PubMed ID: 8557897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of nitrate tolerance with angiotension converting enzyme inhibitors.
    Katz RJ; Levy WS; Buff L; Wasserman AG
    Circulation; 1991 Apr; 83(4):1271-7. PubMed ID: 1901528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enalapril during continuous nitrate therapy: analysis of diameter of coronary arteries and platelet cyclic guanosine monophosphate.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Am Heart J; 1997 Oct; 134(4):614-21. PubMed ID: 9351727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril.
    Heitzer T; Just H; Brockhoff C; Meinertz T; Olschewski M; Münzel T
    J Am Coll Cardiol; 1998 Jan; 31(1):83-8. PubMed ID: 9426022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
    Takaoka A; Nakae I; Takahashi M; Matsumoto T; Liu Q; Mitsunami K; Kinoshita M
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of coronary flow reserve after long-term therapy with enalapril.
    Motz W; Strauer BE
    Hypertension; 1996 May; 27(5):1031-8. PubMed ID: 8621193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
    Hansen EF; Bendtsen F; Henriksen JH
    Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
    Ferro CJ; Spratt JC; Haynes WG; Webb DJ
    Circulation; 1998 Jun; 97(23):2323-30. PubMed ID: 9639376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs.
    Cambridge D; Whiting MV; Butterfield LJ; Allan G
    Br J Pharmacol; 1992 Jun; 106(2):342-7. PubMed ID: 1356560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors.
    Minai K; Matsumoto T; Horie H; Ohira N; Takashima H; Yokohama H; Kinoshita M
    J Am Coll Cardiol; 2001 May; 37(6):1565-70. PubMed ID: 11345366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
    Zanzinger J; Zheng X; Bassenge E
    Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
    van Gilst WH; Tio RA; van Wijngaarden J; de Graeff PA; Wesseling H
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S134-9. PubMed ID: 1381790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilation of epicardial arteries in conscious dogs induced by angiotensin-converting enzyme inhibition with enalaprilat.
    Holtz J; Busse R; Sommer O; Bassenge E
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):348-55. PubMed ID: 2437401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
    Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG
    J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
    Mento PF; Maita ME; Murphy WR; Holt WF; Wilkes BM
    J Cardiovasc Pharmacol; 1993 May; 21(5):791-6. PubMed ID: 7685451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into mechanisms underlying nitrate tolerance.
    Münzel T; Kurz S; Heitzer T; Harrison DG
    Am J Cardiol; 1996 May; 77(13):24C-30C. PubMed ID: 8638523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.